6 Recruiting Lung Non-Small Cell Carcinoma Phase 1 Clinical Trials
Active phase 1 studies for lung non-small cell carcinoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Lung Non-Small Cell Carcinoma studiesPhase 1 Studies for Lung Non-Small Cell Carcinoma
🔵 Active, Not Recruiting Phase1
CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1
Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung Cancer
📍 Roswell Park Cancer Institute — Buffalo, New York
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1
Papaverine and Stereotactic Body Radiotherapy (SBRT) for Non Small Cell Lung Cancer (NSCLC) or Lung Metastases
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
View Study & Checklist ➔ 🟢 Recruiting Phase1
Gilteritinib for the Treatment of ALK NSCLC
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer
📍 Vanderbilt University/Ingram Cancer Center — Nashville, Tennessee
View Study & Checklist ➔ 🟢 Recruiting Early Phase1
Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer
📍 Emory University/Winship Cancer Institute — Atlanta, Georgia
View Study & Checklist ➔